Joshua S. Greer1,2, Yiming Wang2, Limin Zhou2, Tarique Hussain1,2, and Ananth J. Madhuranthakam2,3
1Pediatrics, UT Southwestern Medical Center, Dallas, TX, United States, 2Radiology, UT Southwestern Medical Center, Dallas, TX, United States, 3Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX, United States
Synopsis
Pulmonary
perfusion imaging using ASL has been demonstrated using the pCASL technique
with varying degrees of reproducibility. In this study, a pCASL labeling
strategy is proposed to improve the stability of perfusion signal in the lungs
using cardiac triggering to reduce flow-induced signal variations, and
background suppression to improve SNR. With the proposed technique, high SNR
perfusion images are created with a limited number of signal averages. This
optimized approach may allow full coverage of the lungs in clinically reasonable
scan times.
Introduction
Non-contrast
perfusion imaging using arterial spin labeled (ASL) MRI has been well
established in the lungs using the pulsed-ASL FAIR technique1,2.
However, pseudo-continuous ASL (pCASL) has been shown to offer improved SNR,
and is recommended for brain perfusion imaging3. The
extension of pCASL to study pulmonary perfusion has been non-trivial due to the
highly pulsatile blood flow and complex anatomy of the vasculature, posing a
significant challenge in identifying the vessel of interest for successful
labeling.
pCASL has been
previously demonstrated for pulmonary perfusion imaging4-6.
However, inconsistent results were
achieved due to the extended pCASL repetition time rendering the acquisition
sensitive to cardiac phase5. Cardiac
triggering the acquisition following the post-label delay can ensure consistent
diastolic acquisitions, but the resulting variable post-label delay is not
compatible with background suppression, which has been shown to significantly
improve ASL perfusion images3.
Therefore, the
purpose of this study was to implement a pCASL labeling technique to improve
the stability of the ASL signal in the lungs using an effective cardiac
triggering strategy that is compatible with background suppression and allows
perfusion quantification.Methods
This was a
HIPAA-compliant study approved by the institutional review board. All subjects
provided written informed consent prior to the participation in the study. Figure
1 shows the proposed pCASL sequence that was implemented on a 3T Ingenia
scanner (Philips Healthcare, Best, The Netherlands). The saturation pulses at
the start of the sequence were cardiac triggered4, and the label duration (LD) and post-label delay
(PLD) were reduced compared to timings used in the brain and kidneys3,7, such that the
acquisition occurs during the diastolic period of the following heartbeat, and
were set to 600-750ms depending on the subjects heartrate. This results in consistent diastolic acquisitions to reduce signal
variations introduced by pulsatile flow1,5. Two
background suppression pulses were applied during the PLD to improve SNR and
reduce physiological noise, and a single-shot turbo spin echo (SShTSE) acquisition
was used to reduce susceptibility artifacts in the lungs. A guided breathing
approach was used to reduce motion during the acquisition, and 4-8 signal
averages were acquired in 0:48 - 1:30 minutes. 2D FAIR images were acquired in
each subject for comparison, and a proton-density (M0) image was
acquired for perfusion quantification8.
The proposed
labeling and cardiac triggering strategy was evaluated in 5 healthy volunteers.
These images were compared with previously presented data from an additional 15
volunteers, who were scanned with various approaches applying pCASL in the
lungs, which were progressively modified to improve the stability of the
perfusion signal. These approaches include labeling of the IVC with the start
of the sequence cardiac triggered, IVC labeling with a cardiac triggered
acquisition for more consistent cardiac phase, and RPA labeling with a cardiac
triggered acquisition to reduce the transit time of labeled blood. The coefficient
of variation of the perfusion signal across dynamics was used to evaluate the signal
stability of each of these approaches.Results
The proposed scheme with cardiac triggering and background suppression provided robust pulmonary
perfusion-weighted images with only 3 signal averages (Fig. 2). This approach
also provided consistent perfusion-weighted images across different dynamics,
that are comparable to FAIR (Fig. 3). Additionally, pCASL images demonstrated
reduced vascular signal, since the inflowing perfusion bolus has a fixed
duration, unlike FAIR9.
The average coefficient of variation
across dynamics was 0.74 ± 0.18 (average ± SD) for the IVC labeling approach,
0.80 ± 0.22 for IVC labeling with the cardiac triggered acquisition, 0.62 ±
0.21 for RPA labeling with the cardiac triggered acquisition, and 0.34 ± 0.02
for RPA labeling with the shorter TR and background suppression, indicating
that the proposed approach provides the most stable perfusion signal.
The average perfusion in the five subjects
scanned with the proposed RPA labeling with background suppression technique
was 435 ± 65 mL/100g/min, within the normal expected range2.
Discussion
Previous
attempts at generating pulmonary perfusion maps with pCASL have provided
promising, yet inconsistent results due to variations in cardiac phase of the
acquisition, limited SNR, and extended scan times. The proposed pCASL labeling
and cardiac triggering strategy addressed these limitations and provided
consistent perfusion signal in the lungs. The improved SNR with this technique
allows fewer signal averages to be acquired and should allow full coverage of
the lungs to be achieved in clinically reasonable scan times for complete assessment of pulmonary
perfusion.Acknowledgements
No acknowledgement found.References
1 Greer,
J. S. et al. Non-contrast
quantitative pulmonary perfusion using flow alternating inversion recovery at 3
T: A preliminary study. Magnetic
resonance imaging 46, 106-113
(2018).
2 Bolar, D. S. et al. Quantification of regional pulmonary blood flow using
ASL-FAIRER. Magn Reson Med 55, 1308-1317, doi:10.1002/mrm.20891
(2006).
3 Alsop, D. C. et al. Recommended implementation of arterial spinālabeled
perfusion MRI for clinical applications: a consensus of the ISMRM perfusion
study group and the European consortium for ASL in dementia. 73,
102-116 (2015).
4 Martirosian, P. et al. Measurement of Lung Perfusion Using Optimized
Pseudo-Continuous Arterial Spin Labeling of Pulmonary Arteries and Fast
True-FISP Imaging at 3 Tesla. International
Society for Magnetic Resonance in Medicine (2017).
5 Joshua S. Greer, Xinzeng Wang, Ivan
Pedrosa & Madhuranthakam, A. J. Pulmonary Perfusion using pseudo-continuous
Arterial Spin Labeling. International
Society for Magnetic Resonance in Medicine (2016).
6 Petros Martirosian et al. Measurement of Pulmonary
Perfusion using PCASL True-FISP Imaging at 1.5 Tesla. International Society for Magnetic Resonance in Medicine (2018).
7 Robson, P. M. et al. Volumetric arterial spin-labeled perfusion imaging of the
kidneys with a three-dimensional fast spin echo acquisition. Academic radiology 23, 144-154 (2016).
8 Buxton, R. B. et al. A general kinetic model for quantitative perfusion imaging
with arterial spin labeling. 40, 383-396 (1998).
9 Wong, E. C., Buxton, R. B. &
Frank, L. R. J. M. r. i. m. Quantitative imaging of perfusion using a single
subtraction (QUIPSS and QUIPSS II). 39, 702-708 (1998).